HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R A Feelders Selected Research

Somatostatin Receptors (Somatostatin Receptor)

1/2021Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer.
12/2013Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.
2/2013Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumors.
2/2012Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion.
6/2009Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome.
2/2009Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies.
1/2005Neuroendocrine tumors and somatostatin: imaging techniques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R A Feelders Research Topics

Disease

15Neoplasms (Cancer)
01/2021 - 01/2005
14Cushing Syndrome
01/2018 - 10/2006
11Pituitary ACTH Hypersecretion
04/2015 - 10/2006
9Acromegaly
05/2016 - 01/2004
8Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2021 - 01/2005
6Pituitary Neoplasms (Pituitary Adenoma)
11/2017 - 11/2011
5ACTH-Secreting Pituitary Adenoma
12/2013 - 10/2006
4Adrenocortical Carcinoma
01/2019 - 09/2013
4Carcinoid Tumor (Carcinoid)
06/2012 - 01/2009
3Hypertension (High Blood Pressure)
08/2017 - 02/2014
2Adrenal Cortex Neoplasms (Adrenocortical Cancer)
01/2019 - 12/2016
2Adenoma (Adenomas)
11/2017 - 12/2013
2Acth-Independent Macronodular Adrenal Hyperplasia
12/2012 - 08/2010
1Thrombosis (Thrombus)
01/2022
1Hemorrhage
01/2022
1Adrenocortical Adenoma (Disease, Conn's)
01/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018
1Pheochromocytoma
08/2017
1Paraganglioma (Paragangliomas)
12/2015
1Cardiomyopathies (Cardiomyopathy)
12/2015
1Rheumatoid Arthritis
08/2015
1Atherosclerosis
04/2015
1Dyslipidemias (Dyslipidemia)
04/2015
1Glucose Intolerance
04/2015
1Pain (Aches)
12/2013
1Growth Hormone-Secreting Pituitary Adenoma
12/2013
1Disease Progression
10/2012
1Bone Resorption
06/2012
1Insulinoma
11/2011
1Hypoglycemia (Reactive Hypoglycemia)
11/2011
1Critical Illness (Critically Ill)
07/2009
1Thyroid Neoplasms (Thyroid Cancer)
01/2009
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2009
1Small Cell Carcinoma
01/2009
1Carcinoma (Carcinomatosis)
01/2009

Drug/Important Bio-Agent (IBA)

15Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2021 - 01/2005
14Adrenocorticotropic Hormone (ACTH)FDA Link
11/2017 - 01/2005
10Hydrocortisone (Cortisol)FDA LinkGeneric
01/2018 - 10/2006
7Somatostatin Receptors (Somatostatin Receptor)IBA
01/2021 - 01/2005
5Glucose (Dextrose)FDA LinkGeneric
01/2018 - 08/2003
5pegvisomantFDA LinkGeneric
05/2016 - 05/2005
4Messenger RNA (mRNA)IBA
01/2019 - 07/2009
4Insulin-Like Growth Factor I (IGF-1)IBA
10/2014 - 05/2005
4Dopamine (Intropin)FDA LinkGeneric
02/2014 - 06/2009
4pasireotideIBA
12/2013 - 02/2009
3Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2013
3Hormones (Hormone)IBA
11/2017 - 08/2010
3LigandsIBA
11/2017 - 08/2010
3CatecholaminesIBA
12/2015 - 02/2010
3GlucocorticoidsIBA
08/2015 - 07/2009
3Octreotide (Sandostatin)FDA LinkGeneric
12/2013 - 06/2006
3Dopamine Receptors (Dopamine Receptor)IBA
12/2013 - 06/2009
2MetanephrineIBA
01/2018 - 08/2017
2Mitotane (Lysodren)FDA Link
12/2016 - 09/2013
2Insulin (Novolin)FDA Link
05/2016 - 11/2011
2Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
08/2015 - 07/2009
2Dexamethasone (Maxidex)FDA LinkGeneric
04/2014 - 01/2009
2Dopamine Agonists (Dopamine Agonist)IBA
12/2013 - 01/2009
2CabergolineFDA LinkGeneric
12/2013 - 06/2009
2SteroidsIBA
12/2013 - 08/2003
2Norepinephrine (Noradrenaline)FDA LinkGeneric
08/2010 - 02/2010
1AnticoagulantsIBA
01/2022
1Etoposide (VP 16)FDA LinkGeneric
01/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1Pharmaceutical PreparationsIBA
01/2018
1Biological ProductsIBA
01/2018
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2017
1LH Receptors (LH Receptor)IBA
11/2017
1Adrenergic Receptors (Adrenergic Receptor)IBA
08/2017
1MethyltransferasesIBA
12/2016
1Temozolomide (Temodar)FDA LinkGeneric
12/2016
1Phosphopyruvate Hydratase (Enolase)IBA
04/2016
1AdipokinesIBA
04/2015
1Chromogranin AIBA
01/2013
1Epidermal Growth Factor (EGF)IBA
12/2012
1Ketoconazole (Nizoral)FDA LinkGeneric
12/2012
1Antifungal AgentsIBA
12/2012
1Fluconazole (Zonal)FDA LinkGeneric
12/2012
1Hydroxyindoleacetic AcidIBA
06/2012
1OsteocalcinIBA
06/2012
1Collagen Type I (Type I Collagen)IBA
06/2012
1indoleacetic acid (indole acetic acid)IBA
06/2012
1Serotonin (5 Hydroxytryptamine)IBA
06/2012
1CollagenIBA
06/2012
1somatostatin receptor 2IBA
02/2012
1Mifepristone (RU 486)FDA Link
02/2012
1pentetreotide (OctreoScan)FDA Link
02/2012
1Diazoxide (Hyperstat)FDA Link
11/2011
1Streptozocin (Streptozotocin)FDA Link
11/2011
1Radioisotopes (Radionuclides)IBA
11/2011
1Peptide Receptors (Peptide Receptor)IBA
11/2011
1Corticotropin Receptors (ACTH Receptor)IBA
11/2011
1Epinephrine (Adrenaline)FDA LinkGeneric
08/2010
1glucocorticoid receptor alphaIBA
07/2009
1glucocorticoid receptor betaIBA
07/2009
1O- beta- ribosyl(1''- 2')- guanosine- 5''- phosphateIBA
07/2009
1Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
02/2009

Therapy/Procedure

12Therapeutics
05/2016 - 05/2005
4Drug Therapy (Chemotherapy)
01/2019 - 01/2004
2Adrenalectomy
01/2009 - 10/2006